AllianceBernstein
ORGO icon

AllianceBernstein’s Organogenesis Holdings ORGO Stock Holding History

AllianceBernstein’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Buy
148,320
+24,030
+19% +$58.7K ﹤0.01% 2912
2026
Q1 		$644K Hold
124,290
– – ﹤0.01% 2520
2025
Q4 		$644K Sell
124,290
-25,600
-17% -$124K ﹤0.01% 2534
2025
Q3 		$633K Hold
149,890
– – ﹤0.01% 2557
2025
Q2 		$549K Buy
149,890
+13,860
+10% +$51.7K ﹤0.01% 2587
2025
Q1 		$588K Sell
136,030
-46,660
-26% -$188K ﹤0.01% 2490
2024
Q4 		$585K Sell
182,690
-3,580
-2% -$12K ﹤0.01% 2567
2024
Q3 		$533K Hold
186,270
– – ﹤0.01% 2633
2024
Q2 		$522K Buy
186,270
+26,510
+17% +$71.1K ﹤0.01% 2651
2024
Q1 		$454K Hold
159,760
– – ﹤0.01% 2623
2023
Q4 		$653K Sell
159,760
-10,060
-6% -$28.2K ﹤0.01% 2471
2023
Q3 		$540K Hold
169,820
– – ﹤0.01% 2536
2023
Q2 		$564K Buy
169,820
+32,020
+23% +$94.6K ﹤0.01% 2570
2023
Q1 		$294K Sell
137,800
-3,133
-2% -$7.74K ﹤0.01% 2780
2022
Q4 		$379K Buy
140,933
+18,064
+15% +$52.7K ﹤0.01% 2777
2022
Q3 		$398K Buy
122,869
+11,569
+10% +$52.3K ﹤0.01% 2748
2022
Q2 		$543K Buy
111,300
+10,721
+11% +$66K ﹤0.01% 2648
2022
Q1 		$766K Buy
100,579
+291
+0.3% +$2.25K ﹤0.01% 2516
2021
Q4 		$927K Sell
100,288
-45,433
-31% -$483K ﹤0.01% 2497
2021
Q3 		$2.08M Buy
145,721
+37,750
+35% +$586K ﹤0.01% 2150
2021
Q2 		$1.79M Buy
107,971
+81,271
+304% +$1.51M ﹤0.01% 2258
2021
Q1 		$486K Sell
26,700
-8,800
-25% -$119K ﹤0.01% 2675
2020
Q4 		$267K Buy
35,500
+5,200
+17% +$24.7K ﹤0.01% 2906
2020
Q3 		$116K Buy
30,300
+1,700
+6% +$6.71K ﹤0.01% 3055
2020
Q2 		$110K Buy
28,600
+12,600
+79% +$45.4K ﹤0.01% 3093
2020
Q1 		$52K Buy
+16,000
New +$68.5K ﹤0.01% 3048

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AllianceBernstein's ORGO Position: Q2 2026 in Review

AllianceBernstein increased its Organogenesis Holdings (ORGO) stake by 19% in Q2 2026, buying an estimated $58.7K and bringing the position to 148,320 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

AllianceBernstein first reported a position in ORGO in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.08M in Q3 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • AllianceBernstein held 148,320 shares of Organogenesis Holdings worth $352K as of Q2 2026.
  • AllianceBernstein bought 24,030 Organogenesis Holdings shares in Q2 2026, an estimated $58.7K.
  • Organogenesis Holdings made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2912 holding.
  • AllianceBernstein first reported a position in Organogenesis Holdings in Q1 2020 and has held it in 26 quarters since.
  • AllianceBernstein's Organogenesis Holdings position peaked at $2.08M in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.